Akela Clinical Research Private Limited - Company Profile

It is a chemicals private limited company based in Delhi, Delhi, India, established in 2007.
2007 Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Akela Clinical Research Private Limited

Akela Clinical Research Private Limited, a struck off private limited company, was established on 20 June 2007 in Delhi, Delhi, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24232DL2007PTC165003. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M.

Formerly known as Pharos Research Services Private Limited. Its leadership includes Dilip Pawar (Director), Ravish Dhirendra Barahia (Director). Past directors included Dilip Pawar, Ravish Dhirendra Barahia, Manish Arora. It is based at C/O Tinkle Pharma, K. No. 136/2, V & P. O. Badli, Above Bank Of Baroda, Delhi, Delhi, 110042.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2007PTC165003

  • Registration Number

    165003

  • Incorporation Date

    20 June 2007

  • Authorized Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Company Age 18 Year, 8 Months
Company report

Akela Clinical Research Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Akela Clinical Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Akela Clinical Research Private Limited?
Current Directors
Name Designation Appointment Date Status
Dilip Pawar Director 31 Jul 2008 Current
Ravish Dhirendra Barahia Director 31 Jul 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 01 Aug 2008 Past
Pramod Abcsdd Additional Director 01 Aug 2008 Past
Pramod Abcsdd Director 01 Aug 2008 Past
Pramod Abcsdd Director 01 Aug 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Akela Clinical Research.

Enhance accessibility to Akela Clinical Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Akela Clinical Research revenue growth over time
Akela Clinical Research profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Akela Clinical Research?

Unlock access to Akela Clinical Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Akela Clinical Research?

Unlock and access historical data on people associated with Akela Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Akela Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akela Clinical Research's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Akela Clinical Research
Recent Activity within the Organization
  • Director Appointment

    Dilip Pawar was appointed as a Director was appointed as a Director on 31 Jul 2008 & has been associated with this company since 17 years 7 months . was recorded as a recent event.

  • Director Appointment

    The activity Ravish Dhirendra Barahia was appointed as a Director was appointed as a Director on 31 Jul 2008 & has been associated with this company since 17 years 7 months . was completed.

  • Company Incorporation

    The activity Akela Clinical Research Private Limited was registered on 20 Jun 2007 with Roc Delhi & aged 18 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Akela Clinical Research Private Limited?

The CIN of Akela Clinical Research Private Limited is U24232DL2007PTC165003.

Where is Akela Clinical Research Private Limited headquartered?

Akela Clinical Research Private Limited is headquartered at C/O Tinkle Pharma, K. No. 136/2, V & P. O. Badli, Above Bank Of Baroda, Delhi, Delhi, 110042.

When was Akela Clinical Research Private Limited incorporated?

Akela Clinical Research Private Limited was incorporated on 20 June 2007.

Who are the current directors of Akela Clinical Research Private Limited?

The current directors of Akela Clinical Research Private Limited are

What is the primary industry of Akela Clinical Research Private Limited?

The primary industry of Akela Clinical Research Private Limited is Chemicals.

Is Akela Clinical Research Private Limited a listed company?

Akela Clinical Research Private Limited is unlisted.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available